Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131770198> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3131770198 endingPage "4385" @default.
- W3131770198 startingPage "4377" @default.
- W3131770198 abstract "Facing the problem of matching growth and status, starting work, starting work, starting work, starting work, starting work, starting work, starting work, and the United Arab Emirates. This harmonization - by approving a set of exceptions of this nature has some of the effects and the secret idea behind it.
 As we see him, he relied on the idea of public order in order to set some exceptions related to the inventions themselves by excluding some of them from the requirement to obtain a patent certificate, which is stipulated in Article 6 of the Law on the Organization and Protection of Industrial Property, and he also made exceptions related to the rights established for the inventor, which are It gives him the power to monopolize and dominate the invention if the inventor has what is in conflict with the objectives of scientific research, which is stipulated in Article 19 of the aforementioned law, and we see that the UAE legislator has organized the idea of compulsory licensing contracts for pharmaceutical products in accordance with the interests of both the licensee and the licensee. Both.
 Research problem: considering that the pharmaceutical industry in the UAE is a strategic industry, and because of the fluctuation of drug prices in the global and local market. Therefore, the problem of this research will focus not on the extent to which the pharmaceutical industry in the Emirates can activate its role in the UAE national economy in light of the UAE pharmaceutical legislation, and whether these legislations were able to create a balance between secrecy in the pharmaceutical industry and scientific progress in this industry.
 research assumes:
 1- There is no relationship between advances in the pharmaceutical industry in the UAE and the confidentiality imposed by the TRIPS Agreement.
 2- The UAE’s accession to the TRIPS Agreement had a negative impact on the pharmaceutical industry.
 3- The Emirati legislator was able to create a consensus between commitment to confidentiality and the manufacture of medicines.
 research aims:
 1- Introducing confidentiality in the pharmaceutical industry.
 2- Identifying the main obstacles to the pharmaceutical industry in the UAE.
 3- Developing proposals to activate the role of local legislation to create a balance between confidentiality and the pharmaceutical industry.
 research importance:
 The importance of the research lies in focusing on the balance between confidentiality and the local pharmaceutical industry to have a developmental role. Thus, we will try to reveal the state of the pharmaceutical industry in the UAE. And how to stimulate the pharmaceutical industry through national legislation
 Research methodology: The researcher will rely on a descriptive approach to analyze and characterize the special industrial reality in medicine in the UAE and analyze private legislation
 Based on the foregoing, and in order to understand the position of the Emirati legislator on the idea of secrecy in the pharmaceutical industries more, this requirement must be divided into two studies. In the first, we review the concept of confidentiality in the pharmaceutical industries. Second: the concerted attempts to mitigate the negative effects of confidentiality in the pharmaceutical industries.
" @default.
- W3131770198 created "2021-03-01" @default.
- W3131770198 creator A5004380842 @default.
- W3131770198 date "2021-02-05" @default.
- W3131770198 modified "2023-09-25" @default.
- W3131770198 title "Legal status of pharmaceutical industry secrecy In the UAE legal system" @default.
- W3131770198 doi "https://doi.org/10.17762/pae.v58i1.1515" @default.
- W3131770198 hasPublicationYear "2021" @default.
- W3131770198 type Work @default.
- W3131770198 sameAs 3131770198 @default.
- W3131770198 citedByCount "0" @default.
- W3131770198 crossrefType "journal-article" @default.
- W3131770198 hasAuthorship W3131770198A5004380842 @default.
- W3131770198 hasBestOaLocation W31317701981 @default.
- W3131770198 hasConcept C10138342 @default.
- W3131770198 hasConcept C11413529 @default.
- W3131770198 hasConcept C121332964 @default.
- W3131770198 hasConcept C127413603 @default.
- W3131770198 hasConcept C144133560 @default.
- W3131770198 hasConcept C162324750 @default.
- W3131770198 hasConcept C17744445 @default.
- W3131770198 hasConcept C182306322 @default.
- W3131770198 hasConcept C18762648 @default.
- W3131770198 hasConcept C190253527 @default.
- W3131770198 hasConcept C199539241 @default.
- W3131770198 hasConcept C24890656 @default.
- W3131770198 hasConcept C2776452267 @default.
- W3131770198 hasConcept C2777351106 @default.
- W3131770198 hasConcept C2779057293 @default.
- W3131770198 hasConcept C2779652045 @default.
- W3131770198 hasConcept C2779962950 @default.
- W3131770198 hasConcept C2780560020 @default.
- W3131770198 hasConcept C2781287902 @default.
- W3131770198 hasConcept C34974158 @default.
- W3131770198 hasConcept C41008148 @default.
- W3131770198 hasConcept C71924100 @default.
- W3131770198 hasConcept C78519656 @default.
- W3131770198 hasConcept C96865113 @default.
- W3131770198 hasConcept C98274493 @default.
- W3131770198 hasConceptScore W3131770198C10138342 @default.
- W3131770198 hasConceptScore W3131770198C11413529 @default.
- W3131770198 hasConceptScore W3131770198C121332964 @default.
- W3131770198 hasConceptScore W3131770198C127413603 @default.
- W3131770198 hasConceptScore W3131770198C144133560 @default.
- W3131770198 hasConceptScore W3131770198C162324750 @default.
- W3131770198 hasConceptScore W3131770198C17744445 @default.
- W3131770198 hasConceptScore W3131770198C182306322 @default.
- W3131770198 hasConceptScore W3131770198C18762648 @default.
- W3131770198 hasConceptScore W3131770198C190253527 @default.
- W3131770198 hasConceptScore W3131770198C199539241 @default.
- W3131770198 hasConceptScore W3131770198C24890656 @default.
- W3131770198 hasConceptScore W3131770198C2776452267 @default.
- W3131770198 hasConceptScore W3131770198C2777351106 @default.
- W3131770198 hasConceptScore W3131770198C2779057293 @default.
- W3131770198 hasConceptScore W3131770198C2779652045 @default.
- W3131770198 hasConceptScore W3131770198C2779962950 @default.
- W3131770198 hasConceptScore W3131770198C2780560020 @default.
- W3131770198 hasConceptScore W3131770198C2781287902 @default.
- W3131770198 hasConceptScore W3131770198C34974158 @default.
- W3131770198 hasConceptScore W3131770198C41008148 @default.
- W3131770198 hasConceptScore W3131770198C71924100 @default.
- W3131770198 hasConceptScore W3131770198C78519656 @default.
- W3131770198 hasConceptScore W3131770198C96865113 @default.
- W3131770198 hasConceptScore W3131770198C98274493 @default.
- W3131770198 hasIssue "1" @default.
- W3131770198 hasLocation W31317701981 @default.
- W3131770198 hasLocation W31317701982 @default.
- W3131770198 hasOpenAccess W3131770198 @default.
- W3131770198 hasPrimaryLocation W31317701981 @default.
- W3131770198 hasRelatedWork W12905821 @default.
- W3131770198 hasRelatedWork W15430668 @default.
- W3131770198 hasRelatedWork W16512138 @default.
- W3131770198 hasRelatedWork W19774595 @default.
- W3131770198 hasRelatedWork W23017946 @default.
- W3131770198 hasRelatedWork W24789500 @default.
- W3131770198 hasRelatedWork W2520942 @default.
- W3131770198 hasRelatedWork W29831318 @default.
- W3131770198 hasRelatedWork W30688411 @default.
- W3131770198 hasRelatedWork W9761714 @default.
- W3131770198 hasVolume "58" @default.
- W3131770198 isParatext "false" @default.
- W3131770198 isRetracted "false" @default.
- W3131770198 magId "3131770198" @default.
- W3131770198 workType "article" @default.